Skip to content
MedsAcross

Manufacturer

Acadia Pharmaceuticals

Pharmaceutical manufacturer based in United States
United States
Products listed
6
Molecules
2
Therapy areas
2

Acadia Pharmaceuticals is a pharmaceutical manufacturer based in United States. MedsAcross lists 6 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
United States
Indian manufacturer
No
Also listed as
Acadia Pharmaceuticals B.V., Acadia Pharmaceuticals Inc.
EU marketing authorisation holder
YesSource: European Medicines Agency
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Acadia Pharmaceuticals products through licensed channels, with the documents your regulator needs.

Neurology

4 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Daybue 200 mg/mL oral solutionOral Cold chainTrofinetideUS FDAAvailable on request
Daybue Stix 5000 mg powder for oral solutionOral Cold chainTrofinetideUS FDAAvailable on request
Daybue Stix 6000 mg powder for oral solutionOral Cold chainTrofinetideUS FDAAvailable on request
Daybue Stix 8000 mg powder for oral solutionOral Cold chainTrofinetideUS FDAAvailable on request

Psychiatry

2 presentations

Psychiatry overview
MedicineActive ingredientRegisterAvailability
Nuplazid 10 mg tabletOralPimavanserinUS FDAAvailable on request
Nuplazid 34 mg capsuleOralPimavanserinUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Acadia Pharmaceuticals

Send a request for any of these products. We confirm the licensed source, documents and lead time.